PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development

药理学 医学
作者
Inge A. Ivens,William E. Achanzar,Andreas Baumann,Annamaria Braendli-Baiocco,Joy A. Cavagnaro,Maggie Dempster,B. O. Depelchin,Armando R. Irizarry Rovira,Laura Dill-Morton,Joan H. Lane,Birgit Maria Reipert,Theodora W. Salcedo,Becky Schweighardt,Laurie Tsuruda,Peter L. Turecek,Jennifer Sims
出处
期刊:Toxicologic Pathology [SAGE Publishing]
卷期号:43 (7): 959-983 被引量:179
标识
DOI:10.1177/0192623315591171
摘要

PEGylation (the covalent binding of one or more polyethylene glycol molecules to another molecule) is a technology frequently used to improve the half-life and other pharmaceutical or pharmacological properties of proteins, peptides, and aptamers. To date, 11 PEGylated biopharmaceuticals have been approved and there is indication that many more are in nonclinical or clinical development. Adverse effects seen with those in toxicology studies are mostly related to the active part of the drug molecule and not to polyethylene glycol (PEG). In 5 of the 11 approved and 10 of the 17 PEGylated biopharmaceuticals in a 2013 industry survey presented here, cellular vacuolation is histologically observed in toxicology studies in certain organs and tissues. No other effects attributed to PEG alone have been reported. Importantly, vacuolation, which occurs mainly in phagocytes, has not been linked with changes in organ function in these toxicology studies. This article was authored through collaborative efforts of industry toxicologists/nonclinical scientists to address the nonclinical safety of large PEG molecules (>10 kilo Dalton) in PEGylated biopharmaceuticals. The impact of the PEG molecule on overall nonclinical safety assessments of PEGylated biopharmaceuticals is discussed, and toxicological information from a 2013 industry survey on PEGylated biopharmaceuticals under development is summarized. Results will contribute to the database of toxicological information publicly available for PEG and PEGylated biopharmaceuticals.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Crssss的应助被古德猫宁采纳,获得10
刚刚
桐桐的应助被无畏甜桃采纳,获得10
刚刚
green发布了新的文献求助10
1秒前
hhan完成签到,获得积分10
1秒前
1秒前
深情安青的应助被学习采纳,获得10
2秒前
ZXG完成签到,获得积分10
2秒前
Ava的应助被Reyna采纳,获得10
4秒前
8848完成签到,获得积分10
4秒前
5秒前
吴冠超完成签到,获得积分20
5秒前
5秒前
6秒前
范小米完成签到,获得积分10
6秒前
7秒前
敬意完成签到,获得积分10
7秒前
小杨完成签到 ,获得积分10
8秒前
白猿完成签到 ,获得积分10
8秒前
9秒前
古德猫宁完成签到,获得积分10
9秒前
ccc发布了新的文献求助10
9秒前
整齐的不言完成签到,获得积分10
10秒前
10秒前
11秒前
MaxDYi完成签到,获得积分10
12秒前
kangshuai完成签到,获得积分10
12秒前
14秒前
Shan完成签到,获得积分10
15秒前
16秒前
17秒前
17秒前
大模型的应助被猪伱平安采纳,获得10
19秒前
诚心的海白完成签到 ,获得积分10
19秒前
隐形曼青的应助被喂喂喂采纳,获得10
20秒前
无畏甜桃发布了新的文献求助10
21秒前
英俊的铭的应助被WJ98采纳,获得30
21秒前
zzw发布了新的文献求助10
22秒前
卖苹果的小红帽完成签到,获得积分10
23秒前
23秒前
谷音完成签到,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181940
求助须知:如何正确求助?哪些是违规求助? 9571697
关于积分的说明 21819181
捐赠科研通 7778330
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557767
邀请新用户注册赠送积分活动 2479621